Inventor · disambiguated record
Jean Gudas
Also filed as: GUDAS JEAN · GUDAS JEAN M · GUDAS JEAN MARIE
53 granted patents·15 pending applications·892 citations·filing 1999–2022
99Inventor score
Top patents by PatentIndex Score
68 records- 0197US11559582B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2020·Granted Jan 24, 2023·3 cites·32 claims
- 0297US8013128B2Antibodies and related molecules that bind to PSCA proteinsAGENSYS INC·Filed 2009·Granted Sep 6, 2011·28 cites·22 claims
- 0397US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0497US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0597US7541442B2Antibodies and related molecules that bind to PSCA proteinsAGENSYS INC·Filed 2006·Granted Jun 2, 2009·26 cites·19 claims
- 0696US7947276B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2006·Granted May 24, 2011·18 cites·9 claims
- 0796US7595379B2Antibodies and related molecules that bind to PSCA proteinsAGENSYS INC·Filed 2005·Granted Sep 29, 2009·34 cites·7 claims
- 0896US7202343B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofABGENIX INC·Filed 2003·Granted Apr 10, 2007·78 cites·39 claims
- 0995US8013135B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2006·Granted Sep 6, 2011·16 cites·4 claims
- 1095US7494646B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2004·Granted Feb 24, 2009·38 cites·21 claims
- 1195US7427399B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2006·Granted Sep 23, 2008·21 cites·21 claims
- 1295US7067131B2Methods for using anti-MUC18 antibodiesABGENIX INC·Filed 2002·Granted Jun 27, 2006·61 cites·21 claims
- 1394US8309093B2Antibody drug conjugates (ADC) that bind to 24P4C12 proteinsGUDAS JEAN·Filed 2010·Granted Nov 13, 2012·19 cites·15 claims
- 1493US10894090B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2018·Granted Jan 19, 2021·4 cites·38 claims
- 1593US9314538B2Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2015·Granted Apr 19, 2016·9 cites·33 claims
- 1693US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 1793US8206932B2Antibodies and related molecules that bind to PSCA proteinsGUDAS JEAN·Filed 2009·Granted Jun 26, 2012·11 cites·7 claims
- 1893US7811565B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2009·Granted Oct 12, 2010·20 cites·20 claims
- 1993US7378091B2Antibodies against carbonic anhydrase IX (CA IX) tumor antigenAMGEN FREMONT INC·Filed 2002·Granted May 27, 2008·44 cites·25 claims
- 2092US9078931B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2013·Granted Jul 14, 2015·11 cites·8 claims
- 2191US10100121B2Anti-mesothelin binding proteinsAMGEN INC·Filed 2016·Granted Oct 16, 2018·5 cites·25 claims
- 2291US9962454B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2016·Granted May 8, 2018·6 cites·5 claims
- 2391US8278424B2Antibodies that bind to PSCA proteins for diagnosis of cancerGUDAS JEAN·Filed 2011·Granted Oct 2, 2012·13 cites·18 claims
- 2491US8039597B2Antibodies and related molecules that bind to 24P4C12 proteinsAGENSYS INC·Filed 2008·Granted Oct 18, 2011·11 cites·24 claims
- 2591US7939503B2Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNAAGENSYS INC·Filed 2004·Granted May 10, 2011·17 cites·1 claims
- 2690US9617346B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2015·Granted Apr 11, 2017·6 cites·16 claims
- 2790US8637642B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsSATPAYEV DAULET·Filed 2011·Granted Jan 28, 2014·12 cites·15 claims
- 2890US8008442B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2004·Granted Aug 30, 2011·22 cites·23 claims
- 2989US11254744B2Antigen binding constructs to target moleculesIMAGINAB INC·Filed 2016·Granted Feb 22, 2022·5 cites·32 claims
- 3089USRE48389EAntibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2017·Granted Jan 12, 2021·2 cites·110 claims
- 3189US6210924B1Overexpressing cyclin D 1 in a eukaryotic cell lineAMGEN INC·Filed 1999·Granted Apr 3, 2001·73 cites·18 claims
- 3288US10597463B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2017·Granted Mar 24, 2020·4 cites·17 claims
- 3388US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 3487US8350009B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2010·Granted Jan 8, 2013·6 cites·8 claims
- 3587US7482434B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofASTRAZENECA AB·Filed 2006·Granted Jan 27, 2009·8 cites·24 claims
- 3686US9023605B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsJAKOBOVITS AYA·Filed 2011·Granted May 5, 2015·6 cites·33 claims
- 3786US2023346968A1Antibody drug conjugates (adc) that bind to 191p4d12 proteinsAGENSYS INC·Filed 2022·Application pending·0 cites
- 3884US11266745B2Extension sequences for diabodiesIMAGINAB INC·Filed 2018·Granted Mar 8, 2022·3 cites·25 claims
- 3984US8236310B2Antibodies and related molecules that bind to 161P2F10B proteinsJAKOBOVITS AYA·Filed 2010·Granted Aug 7, 2012·6 cites·17 claims
- 4083US9308278B2Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsAGENSYS INC·Filed 2013·Granted Apr 12, 2016·4 cites·14 claims
- 4182US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 4282US8609092B2Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsTORGOV MICHAEL·Filed 2011·Granted Dec 17, 2013·6 cites·5 claims
- 4381US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 4481US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 4580US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
- 4679US7358353B2Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2004·Granted Apr 15, 2008·7 cites·4 claims
- 4775US10508153B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2015·Granted Dec 17, 2019·1 cites·61 claims
- 4875US8945570B2Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2012·Granted Feb 3, 2015·1 cites·16 claims
- 4975US7687606B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofASTRAZENECA AB·Filed 2006·Granted Mar 30, 2010·1 cites·33 claims
- 5071US11866508B2Anti-mesothelin binding proteinsAMGEN INC·Filed 2021·Granted Jan 9, 2024·0 cites·26 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →